… cells with erlotinib, an inhibitor of EGFR, in the absence or presence of OM for 48 h. The results
indicated that in the presence of both erlotinib … and increases the risk of tumor recurrence (…

… common type of liver cancer worldwide. It is estimated to be … can also induce cell cycle
regulation and apoptosis through … cells and neuroblastoma Neuroa2a cells led to an increase in …

… enhanced expression of cyclin E1 after transfection compromised apoptosis in HCC cells
induced … The suppression of cell cycle regulator levels by sorafenib may enhance its antitumor …

… proved to be a reliable approach to enhance drug release and bioavailability. Our results …
lotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances …

… and subsequently induced cell cycle G2/M arrest associated … (p53-dependent) but also to
increase the protein levels of … enzyme inhibitor, Erlotinib, was applied for treatment of advanced …

… into cancer chemotherapy. However, the therapeutic effects of erlotinib in hepatocellular
carcinoma (… 2ME2 promotes tumor cells apoptosis and inhibits tumor cells proliferative in several …

… ) in hepatocellular carcinoma cells. Capsaicin enhances apoptosis and restricts benzo(a)pyrene
induced … effects of a combined treatment using erlotinib and capsaicin on NSCLC cells. …

… Cell cycle arrest can save time for DNA repair. On the other hand, if the intracellular damage
… of tumors including lung cancer, liver cancer, digestive tract cancer, and bladder cancer, etc.…

… Gefitinib and erlotinib are epidermal growth factor receptor (… a survival benefit for advanced
hepatocellular carcinoma (HCC). … failed to enhance apoptosis in both NSCLC and HCC cells. …

… plus erlotinib could increase the expression of E-cadherin; thus, we hypothesized that aspirin
plus erlotinib may inhibit EMT and cancer metastasis. EMT enables cancer cell migration …